Gilead Sciences's total assets for Q2 2025 were $55.72B, a decrease of -1.26% from the previous quarter. GILD total liabilities were $36.13B for the fiscal quarter, a -3.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.